Open AccessLiving donor liver transplantation to patients with hepatitis C virus cirrhosis
Author(s) -
Yasuhiko Sugawara,
Masatoshi Makuuchi
Publication year - 2006
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v12.i28.4461
Subject(s) - medicine , cirrhosis , liver transplantation , hepatitis c virus , economic shortage , hepatitis c , transplantation , living donor liver transplantation , virus , gastroenterology , immunology , linguistics , philosophy , government (linguistics)
Living donor liver transplantation (LDLT) is an alternative therapeutic option for patients with end-stage hepatitis C virus (HCV) cirrhosis because of the cadaveric organ shortage. HCV infection is now a leading indication for LDLT among adults worldwide, and there is a worse prognosis with HCV recurrence. The antivirus strategy after transplantation, however, is currently under debate. Recent updates on the clinical and therapeutic aspects of living donor liver transplantation for HCV are discussed in the present review.